190 related articles for article (PubMed ID: 28445279)
1. Promoter hypermethylation of MGMT gene may contribute to the pathogenesis of gastric cancer: A PRISMA-compliant meta-analysis.
Zhang Z; Xin S; Gao M; Cai Y
Medicine (Baltimore); 2017 Apr; 96(17):e6708. PubMed ID: 28445279
[TBL] [Abstract][Full Text] [Related]
2. The Association Between MGMT Promoter Methylation and Patients with Gastric Cancer: A Meta-Analysis.
Yuan X; Xu J; Fang W; Zhao Z; Wang F; Tong Z
Genet Test Mol Biomarkers; 2017 Apr; 21(4):213-221. PubMed ID: 28384044
[TBL] [Abstract][Full Text] [Related]
3. MGMT gene silencing by promoter hypermethylation in gastric cancer in a high incidence area.
Yousuf A; Bhat MY; Pandith AA; Afroze D; Khan NP; Alam K; Shah P; Shah MA; Mudassar S
Cell Oncol (Dordr); 2014 Aug; 37(4):245-52. PubMed ID: 25008999
[TBL] [Abstract][Full Text] [Related]
4. Associations of MGMT promoter hypermethylation with squamous intraepithelial lesion and cervical carcinoma: A meta-analysis.
Huang J; Luo JY; Tan HZ
PLoS One; 2019; 14(10):e0222772. PubMed ID: 31574102
[TBL] [Abstract][Full Text] [Related]
5. Impact of catechol-O-methyltransferase gene variants on methylation status of P16 and MGMT genes and their downregulation in colorectal cancer.
Wani HA; Majid S; Bhat AA; Amin S; Farooq R; Bhat SA; Naikoo NA; Beigh MA; Kadla SA
Eur J Cancer Prev; 2019 Mar; 28(2):68-75. PubMed ID: 30379684
[TBL] [Abstract][Full Text] [Related]
6. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
7. Aberrant DNA methylation of MGMT and hMLH1 genes in prediction of gastric cancer.
Jin J; Xie L; Xie CH; Zhou YF
Genet Mol Res; 2014 May; 13(2):4140-5. PubMed ID: 24938706
[TBL] [Abstract][Full Text] [Related]
8. Association Between MGMT Promoter Methylation and Breast Cancer: a Meta-Analysis.
An N; Shi Y; Ye P; Pan Z; Long X
Cell Physiol Biochem; 2017; 42(6):2430-2440. PubMed ID: 28848211
[TBL] [Abstract][Full Text] [Related]
9. Association between MGMT Promoter Methylation and Risk of Breast and Gynecologic Cancers: A Systematic Review and Meta-Analysis.
Chen R; Zheng Y; Zhuo L; Wang S
Sci Rep; 2017 Oct; 7(1):12783. PubMed ID: 28986566
[TBL] [Abstract][Full Text] [Related]
10. Association of MGMT promoter methylation with tumorigenesis features in patients with ovarian cancer: A systematic meta-analysis.
Qiao B; Zhang Z; Li Y
Mol Genet Genomic Med; 2018 Jan; 6(1):69-76. PubMed ID: 29195029
[TBL] [Abstract][Full Text] [Related]
11. Abnormal MGMT promoter methylation may contribute to the risk of esophageal cancer: a meta-analysis of cohort studies.
Zhao JJ; Li HY; Wang D; Yao H; Sun DW
Tumour Biol; 2014 Oct; 35(10):10085-93. PubMed ID: 25015189
[TBL] [Abstract][Full Text] [Related]
12. [Frequent promoter hypermethylation of several tumor suppressor genes in gastric carcinoma and foveolar epithelium].
Cai JC; Liu D; Zhang HP; Zhong S; Xia NS
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):510-3. PubMed ID: 18069630
[TBL] [Abstract][Full Text] [Related]
13. Promoter Hypermethylation and Its Impact on Expression of MGMT Gene in the GIT Malignant Patients of Kashmiri Origin.
Bhat AA; Wani HA; Ishaq S; Waza AA; Malik RA; Shabir I; Jeelani S; Kadla S; Qureshie W; Masood A; Majid S
Cancer Invest; 2017 Feb; 35(2):116-121. PubMed ID: 28135856
[TBL] [Abstract][Full Text] [Related]
14. Role of P14 and MGMT gene methylation in hepatocellular carcinomas: a meta-analysis.
Li CC; Yu Z; Cui LH; Piao JM; Liu M
Asian Pac J Cancer Prev; 2014; 15(16):6591-6. PubMed ID: 25169493
[TBL] [Abstract][Full Text] [Related]
15. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.
Koutsimpelas D; Pongsapich W; Heinrich U; Mann S; Mann WJ; Brieger J
Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327
[TBL] [Abstract][Full Text] [Related]
16. Promoter methylation as biomarkers for diagnosis of melanoma: A systematic review and meta-analysis.
Guo Y; Long J; Lei S
J Cell Physiol; 2019 May; 234(5):7356-7367. PubMed ID: 30370527
[TBL] [Abstract][Full Text] [Related]
17. MGMT gene promoter methylation in humoral tissue as biomarker for lung cancer diagnosis: An update meta-analysis.
Chen B; Ying X; Bao L
Thorac Cancer; 2021 Dec; 12(23):3194-3200. PubMed ID: 34651448
[TBL] [Abstract][Full Text] [Related]
18. The value of MGMT promote methylation and IDH-1 mutation on diagnosis of pseudoprogression in patients with high-grade glioma: A meta-analysis.
Zhou M; Niu C; Jia L; He H
Medicine (Baltimore); 2019 Dec; 98(50):e18194. PubMed ID: 31852075
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori CagA induces tumor suppressor gene hypermethylation by upregulating DNMT1 via AKT-NFκB pathway in gastric cancer development.
Zhang BG; Hu L; Zang MD; Wang HX; Zhao W; Li JF; Su LP; Shao Z; Zhao X; Zhu ZG; Yan M; Liu B
Oncotarget; 2016 Mar; 7(9):9788-800. PubMed ID: 26848521
[TBL] [Abstract][Full Text] [Related]
20. Kras gene mutation and RASSF1A, FHIT and MGMT gene promoter hypermethylation: indicators of tumor staging and metastasis in adenocarcinomatous sporadic colorectal cancer in Indian population.
Sinha R; Hussain S; Mehrotra R; Kumar RS; Kumar K; Pande P; Doval DC; Basir SF; Bharadwaj M
PLoS One; 2013; 8(4):e60142. PubMed ID: 23573237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
